Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows

v3.23.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Mar. 31, 2023
Mar. 31, 2022
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net earnings, including noncontrolling interest $ 209,958 $ 201,184
Adjustments to reconcile net earnings to net cash provided by operating activities:    
Depreciation and amortization 80,315 75,203
Costs recognized on sale of acquired inventory 400 1,596
Deferred income taxes (22,651) 7,888
Stock-based compensation expense 41,315 33,777
Fair value adjustment to contingent consideration payable (10,350) (20,600)
Contingent consideration payments - operating   (3,300)
(Gain) Loss on investment, net (37,176)  
Fair value adjustment on available-for-sale investments (1,153) (15,569)
Asset impairment restructuring 0 546
Eminence impairment   18,715
Gain on sale of Eminence (11,682) 0
Leases, net 1,434 (974)
Other operating activity 296 549
Change in operating assets and operating liabilities, net of acquisition:    
Trade accounts and other receivables, net (20,775) (60,930)
Inventories (28,816) (16,034)
Prepaid expenses (5,557) (3,576)
Trade accounts payable, accrued expenses, contract liabilities, and other (5,647) 11,229
Salaries, wages and related accruals (22,759) 2,059
Income taxes payable 3,848 (9,208)
Net cash provided by (used in) operating activities 171,000 222,555
CASH FLOWS FROM INVESTING ACTIVITIES:    
Proceeds from maturities of available-for-sale investments 29,161 26,055
Purchases of available-for-sale investments (20,500) (47,998)
Proceeds from sale of CCXI investment 73,219  
Additions to property and equipment (27,413) (31,338)
Acquisitions, net of cash acquired (101,184)  
Proceeds from sale of Eminence 17,824  
Investment of forward purchase contract   (25,000)
Investment in Wilson Wolf (232,000)  
Net cash provided by (used in) investing activities (260,893) (78,281)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Cash dividends (37,688) (37,646)
Proceeds from stock option exercises 21,399 68,346
Re-purchases of common stock (19,562) (102,132)
Borrowings under line-of-credit agreement 619,661 90,000
Repayments of long-term debt (505,661) (172,375)
Contingent consideration payments - financing 0 (700)
Taxes paid on RSUs and net share settlements (28,854) (23,406)
Other financing activity (2,457) 788
Net cash provided by (used in) financing activities 46,838 (177,125)
Effect of exchange rate changes on cash and cash equivalents (2,230) (5,419)
Net change in cash and cash equivalents (45,285) (38,270)
Cash and cash equivalents at beginning of period 172,567 199,091
Cash and cash equivalents at end of period 127,282 160,821
Supplemental disclosure of cash flow information:    
Cash paid for income taxes 62,583 22,965
Cash paid for interest $ 5,773 $ 8,522